CDT Equity Inc.
- CDT
- NASDAQ
- Biotechnology
- Clinical-Stage Biotech
$0.24
Today +12.49%Quote Oct 16, 2026, 08:00 PM UTC
−95.04%over the last month
Max drawdown −95.6%From 1-month high −95.0%3 months −99.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$1.5M
Quote Oct 16
Next earnings
—
Data unavailable
Latest analyst target
—
Data unavailable
Floor
—
Data unavailable
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CDTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $750.2M
- Automation Solutions$436.8M58.2%
- Smart Buildings Solutions$156.4M20.8%
- Other / not reported$157.0M20.9%
Industry
Biotechnology
Employees
4
Founded
2019